GALA Dallas Conference – 2018

Click link for access to slides.

WELCOME/INTRODUCTION • Conference Chairs: Mack Mitchell, MD, and Lawrence Schiller, MD

EVALUATION OF CHRONIC DIARRHEA AND IBS-D IN THE ERA OF PRECISION MEDICINE • Lawrence Schiller, MD

CHRONIC IDIOPATHIC CONSTIPATION AND OPIOID-INDUCED CONSTIPATION: THE SAME BUT DIFFERENT • William Chey, MD

GUT MICROBIOTA AND GASTROINTESTINAL HEALTH: THE BASICS AND WHAT’S NEW • Christopher Chang, MD

AN UPDATE ON THE PHARMACOLOGIC TREATMENT OF NAFLD/NASH: BEYOND LIFESTYLE MODIFICATIONS • Naim Alkhouri, MD

AUTOIMMUNE BILIARY DISEASE: DIAGNOSIS AND MANAGEMENT OF PBC AND PSC • John Vierling, MD

ALCOHOL-RELATED HEPATITIS • Mack Mitchell, MD

CURRENT DILEMMAS IN CHRONIC HEPATITIS C MANAGEMENT

CASE 1: HOW TO CHOOSE YOUR HCV THERAPY: A NUC OR PI BASED REGIMEN • Robert Brown, MD

CASE 2: DEALING WITH HBV COINFECTION, RISK OF HCC AFTER SVR AND TREATING PATIENTS WITH CIRRHOSIS AND RENAL IMPAIRMENT • Paul Kwo, MD

CURRENT DILEMMAS IN DIAGNOSING LIVER MASSES

CASE 1: DIAGNOSIS AND MANAGEMENT OF BENIGN LIVER TUMORS: HOW TO DISTINGUISH LESIONS WITH IMAGING AND WHEN A BIOPSY IS NEEDED • Kimberly Brown, MD

CASE 2: DIAGNOSIS AND MANAGEMENT OF HCC: RESECT, ABLATE OR TRANSPLANT? WHEN IS A BIOPSY NEEDED AND WHEN IS AN ONCOLOGIST NEEDED? • Laura Kulik, MD

THE EVOLVING ROLE OF THERAPEUTIC DRUG MONITORING IN IBD • Gary Lichtenstein, MD

UPDATE ON IMMUNOMODULATORS IN IBD • Themistocles Dassopoulos, MD

THE DIAGNOSIS AND MANAGEMENT OF HEREDITARY COLORECTAL CANCER SYNDROMES • C. Richard Boland, MD

PROTON PUMP INHIBITORS: HOW AND WHEN TO USE IN THE CURRENT ENVIRONMENT • Stuart Spechler, MD

REFRACTORY HEARTBURN: ALL ROADS LEAD TO ROME • Ronnie Fass, MD

ACHALASIA: CURRENT DIAGNOSTIC WORKUP AND MANAGEMENT • Vani Konda, MD

Author Info

Sean Hendrickson